Benjamin Scherlag to In Vitro Techniques
This is a "connection" page, showing publications Benjamin Scherlag has written about In Vitro Techniques.
Connection Strength
0.254
-
The elusive extracellular AV nodal potential: studies from the canine heart, ex vivo. J Interv Card Electrophysiol. 2002 Aug; 7(1):39-52.
Score: 0.048
-
Demonstration of the exact anatomic tachycardia circuit in the fast-slow form of atrioventricular nodal reentrant tachycardia. Circulation. 2002 Apr 09; 105(14):e80-1; author reply e80-1.
Score: 0.047
-
Is there longitudinal dissociation in the undamaged his bundle? In vitro studies in the normal canine heart. J Electrocardiol. 2000; 33 Suppl:83-6.
Score: 0.040
-
Extra- and intracellular recordings from the avjunction: discerning the mechanisms for irregular ventricular responses during supraventricular arrhythmias. Acta Cardiol. 2012 Apr; 67(2):221-9.
Score: 0.023
-
Effect of GLG-V-13, a class III antiarrhythmic agent, on potassium currents in rabbit ventricular myocytes. Life Sci. 2000 Mar; 66(17):PL 253-8.
Score: 0.010
-
Effects of lidocaine on hypoxic and ischemic cardiac cells. Am J Cardiol. 1978 May 01; 41(5):872-9.
Score: 0.009
-
Facilitation of epinephrine-induced afterdepolarizations by class III antiarrhythmic drugs. J Electrocardiol. 1997 Jul; 30(3):217-24.
Score: 0.008
-
Early afterdepolarizations produced by d,l-sotalol and clofilium. J Cardiovasc Electrophysiol. 1997 Jun; 8(6):667-78.
Score: 0.008
-
Electrophysiology of the right anterior approach to the atrioventricular node: studies in vivo and in the isolated perfused dog heart. J Cardiovasc Electrophysiol. 1997 Jan; 8(1):47-61.
Score: 0.008
-
Electrophysiological and inotropic characterization of a novel class III antiarrhythmic agent, GLG-V-13, in the mammalian heart. J Cardiovasc Pharmacol. 1996 Aug; 28(2):182-91.
Score: 0.008
-
Regional refractoriness within the ventricular conduction system. An evaluation of the "gate" hypothesis. Circ Res. 1976 Aug; 39(2):254-62.
Score: 0.008
-
Electrophysiological characterization of a novel class III antiarrhythmic agent, GLG-V-13 in the mammalian heart. Acta Physiol Hung. 1995; 83(1):13-30.
Score: 0.007
-
Early and late effects of coronary artery occlusion on canine Purkinje fibers. Circ Res. 1974 Sep; 35(3):391-9.
Score: 0.007
-
Functional dissociation of cellular activation as a mechanism of Mobitz type II atrioventricular block. Circulation. 1993 Apr; 87(4):1389-98.
Score: 0.006
-
Conversion of Mobitz type II AV block to 1:1 AV conduction by premature ventricular beats. J Electrocardiol. 1992; 25 Suppl:165-72.
Score: 0.006
-
Electrophysiological actions of BRB-I-28 in canine myocardial tissues. J Pharmacol Exp Ther. 1991 Nov; 259(2):558-65.
Score: 0.006
-
New method for measuring myocardial blood flow by high resolution scintigraphy in the excised dog heart. J Nucl Med. 1986 Oct; 27(10):1586-92.
Score: 0.004